BCMA Directed Therapies

This space covers BCMA-targeted therapies, which are newer treatments used for multiple myeloma that focus on a specific protein found on myeloma cells called B-cell maturation antigen (BCMA). By zeroing in on this protein, these therapies work to destroy myeloma cells while aiming to spare most healthy cells. Here, you will find clear information about how treatments like CAR T-cell therapy and bispecific antibodies work, their potential side effects, and how they fit into a treatment plan. You can also connect with others to share day-to-day experiences, practical tips, and questions about what to expect before, during, and after therapy.